Ebit Veränderung Datum
AbbVie USD 5.24B 1.5B 2024-12
Agios Pharmaceuticals USD -125037000 22.23M 2024-12
Alnylam Pharmaceuticals USD -105159000 28.25M 2024-12
Amgen USD 4.03B 11M 2024-12
Astellas Pharma JPY -44475000000 63.86B 2024-03
AstraZeneca USD 4.8B 604M 2025-03
Biogen USD 644.1M 100.9M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Bristol-Myers Squibb USD 4.18B 30M 2025-03
Eli Lilly USD 5.63B 3.88B 2024-12
Gilead Sciences USD 2.89B 221M 2025-03
GlaxoSmithKline GBP 2.53B 1.1B 2025-03
Incyte USD 283.64M 92.62M 2025-03
Ionis Pharmaceuticals USD -110000000 38M 2024-12
J&J USD 7.39B 2.04B 2025-03
Kyowa Hakko Kirin JPY 29.15B 10.86B 2024-06
Merck USD 5.22B 339M 2024-12
Moderna USD -1246000000 1.18B 2024-12
Neurocrine Biosciences USD 142M 41.8M 2024-12
Novartis USD 4.86B 286M 2024-12
Novartis USD 4.86B 286M 2024-12
Pfizer USD 5.93B 1.31B 2025-03
Regeneron Pharmaceuticals USD 1.57B 67.9M 2024-12
Roche Holding CHF 11.29B 2.68B 2024-06
Sanofi EUR 2.22B 2.84B 2024-12
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
Teva Pharmaceutical Industries USD 1.17B 100M 2024-12
Ultragenyx Pharmaceutical USD -122278000 9.71M 2024-12
United Therapeutics USD 357.7M 14.6M 2024-12
Vertex Pharmaceuticals USD 1.2B 108.8M 2024-12



Regeneron Pharmaceuticals - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.